Thoma Bravo in advanced talks to acquire NextGen Healthcare

Last month, Reuters reported that NextGen is considering various possibilities, including selling the company.

RanjithKumar Dharma September 06 2023

Private equity company Thoma Bravo is in advanced discussions to purchase NextGen Healthcare, a company that specialises in health records software, reported Bloomberg News.

A deal could be finalised this week, the news agency stated, citing people with knowledge of the development.

Despite this, there has not been a definitive decision on the matter yet, and the talks may not lead to a conclusion. NextGen is currently valued at approximately $1.3bn.

Neither of the parties involved have confirmed the development.

Before Thoma Bravo began negotiations, other buyout firms had also shown interest in NextGen, as per the unnamed sources.

Last month, Reuters reported that NextGen is considering various possibilities, which includes divesting the business.

In 2022, the firm’s competitor Cerner was acquired by Oracle for $28bn.              

Based in Atlanta, Georgia, NextGen offers electronic health record (EHR) software and practice management systems for the healthcare sector.

The company’s service suite includes credentialing and fee schedules, managed cloud hosting, documentation management, revenue cycle management, training, and professional services, among others.

Last month, NextGen announced the expansion of its alliance with Luma Health to deliver artificial intelligence (AI)-enhanced patient communication tools to US ambulatory organisations.

The companies will work together to integrate Luma-powered NextGen Patient Engage and NextGen Self-Scheduling into NextGen Enterprise EHR.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close